title: Severe and refractory peptic ulcer disease: the diagnostic dilemma: case report and comprehensive review.
abstract: The recognition of Helicobacter pylori infection as a cause of peptic ulcer disease, medical regimens to eradicate the organism, and the widespread use of proton pump inhibition to suppress gastric acid secretion have revolutionized the management of peptic ulcer disease. As a result, successful medical management of peptic ulcer disease has largely supplanted the need for gastric surgery by general surgeons. Surgery is reserved for complications of the disease, refractory disease, or rare causes of ulcer disease such as gastrinoma and Zollinger-Ellison syndrome. In this report, we describe a case of intractable peptic ulcer disease that progressed to gastric outlet obstruction despite maximal medical therapy. We review the diagnostic studies utilized to evaluate the potential etiologies of peptic ulcer disease and the difficulty in diagnosing gastrinoma and Zollinger-Ellison in the setting of potent medical acid suppression therapy.
authors.affiliation: Department of Surgery, University of Maryland, Baltimore, Maryland, USA.
authors.forename: James L
authors.initials: JL
authors.lastname: Guzzo
authors.forename: Mona
authors.initials: M
authors.lastname: Duncan
authors.forename: Barbara L
authors.initials: BL
authors.lastname: Bass
authors.forename: Grant V
authors.initials: GV
authors.lastname: Bochicchio
authors.forename: Lena M
authors.initials: LM
authors.lastname: Napolitano
mesh_terms: D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D005260:Female; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D010437:Peptic Ulcer / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012008:Recurrence; D012307:Risk Factors
chemical_list: D000897:Anti-Ulcer Agents